title: Can median nail dystrophy be an adverse effect of alitretinoin treatment?
authors.affiliation: Department of Dermatology and Allergy Centre, Odense University Hospital, DK-5000 Odense, Denmark.
authors.forename: Anna Hillert
authors.initials: AH
authors.lastname: Winther
authors.forename: Anette
authors.initials: A
authors.lastname: Bygum
mesh_terms: D000077556:Alitretinoin; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects*; D057915:Drug Substitution; D004485:Eczema / Q000175:diagnosis / Q000188:drug therapy*; D005533:Foot Dermatoses / Q000175:diagnosis / Q000188:drug therapy*; D006229:Hand Dermatoses / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced* / Q000175:diagnosis; D009264:Nails, Malformed / Q000139:chemically induced* / Q000175:diagnosis; D013997:Time Factors; D016896:Treatment Outcome; D014212:Tretinoin / Q000009:adverse effects*
chemical_list: D003879:Dermatologic Agents; D000077556:Alitretinoin; D014212:Tretinoin; D016572:Cyclosporine